Magnetic resonance imaging in progressive supranuclear palsy

[1]  W. Poewe,et al.  Diagnostic accuracy of the magnetic resonance Parkinsonism index and the midbrain‐to‐pontine area ratio to differentiate progressive supranuclear palsy from Parkinson's disease and the Parkinson variant of multiple system atrophy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[2]  M. Filippi,et al.  The in vivo distribution of brain tissue loss in Richardson’s syndrome and PSP‐parkinsonism: a VBM‐DARTEL study , 2010, The European journal of neuroscience.

[3]  Maria Stamelou,et al.  In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: A DTI study using TBSS , 2010, Movement disorders : official journal of the Movement Disorder Society.

[4]  Klaus Seppi,et al.  Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. , 2010, Neuroimaging clinics of North America.

[5]  A. Bronstein,et al.  Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: A neuropsychological and neuroimaging analysis , 2010, Movement disorders : official journal of the Movement Disorder Society.

[6]  A. Bizzi,et al.  Diffusion Tensor Imaging Shows Different Topographic Involvement of the Thalamus in Progressive Supranuclear Palsy and Corticobasal Degeneration , 2009, American Journal of Neuroradiology.

[7]  Roberto Cabeza,et al.  Assessing the effects of age on long white matter tracts using diffusion tensor tractography , 2009, NeuroImage.

[8]  David R Williams,et al.  Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges , 2009, The Lancet Neurology.

[9]  C. Schade-Brittinger,et al.  In vivo Evidence for Cerebral Depletion in High-Energy Phosphates in Progressive Supranuclear Palsy , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  D. Dickson.  Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration , 1999, Journal of Neurology.

[11]  Aldo Quattrone,et al.  Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[12]  Giovanni Rizzo,et al.  Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. , 2008, Brain : a journal of neurology.

[13]  T. Hattori,et al.  Diffusion tensor analysis of corpus callosum in progressive supranuclear palsy , 2008, Neuroradiology.

[14]  Nick C. Fox,et al.  Ten simple rules for reporting voxel-based morphometry studies , 2008, NeuroImage.

[15]  C. Jack,et al.  Voxel-based morphometry in autopsy proven PSP and CBD , 2008, Neurobiology of Aging.

[16]  D. Dickson,et al.  Clinical and neuropathologic features of progressive supranuclear palsy with severe pallido-nigro-luysial degeneration and axonal dystrophy. , 2008, Brain : a journal of neurology.

[17]  Francesco Fera,et al.  MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. , 2008, Radiology.

[18]  David Neil Manners,et al.  Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.. Dec 15;23(16):2370-6.PMID: 18816803 , 2008 .

[19]  T. Taoka,et al.  Signal changes of superior cerebellar peduncle on fluid-attenuated inversion recovery in progressive supranuclear palsy. , 2008, Parkinsonism & related disorders.

[20]  A. Lees,et al.  Pure akinesia with gait freezing: A third clinical phenotype of progressive supranuclear palsy , 2007, Movement disorders : official journal of the Movement Disorder Society.

[21]  W. Kamphorst,et al.  Frontal presentation in progressive supranuclear palsy , 2007, Neurology.

[22]  C. Bartolozzi,et al.  Assessment of midbrain atrophy in patients with progressive supranuclear palsy with routine magnetic resonance imaging , 2007, Acta neurologica Scandinavica.

[23]  Nick C Fox,et al.  MRI derived brain atrophy in PSP and MSA-P , 2007, Journal of neurology.

[24]  J. Moffett,et al.  N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.

[25]  Dennis W Dickson,et al.  Progressive Supranuclear Palsy: Pathology and Genetics , 2007, Brain pathology.

[26]  D. Dickson,et al.  MR imaging of brainstem atrophy in progressive supranuclear palsy , 2007, Journal of Neurology.

[27]  S. Brockstedt,et al.  Tracking the neurodegeneration of parkinsonian disorders – a pilot study , 2007, Neuroradiology.

[28]  G J Barker,et al.  Measuring brain stem and cerebellar damage in parkinsonian syndromes using diffusion tensor MRI , 2006, Neurology.

[29]  Takeo Kato,et al.  Upper midbrain profile sign and cingulate sulcus sign: MRI findings on sagittal images in idiopathic normal-pressure hydrocephalus, Alzheimer's disease, and progressive supranuclear palsy , 2006, Radiation Medicine.

[30]  J. Thiran,et al.  Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. , 2006, Radiographics : a review publication of the Radiological Society of North America, Inc.

[31]  Daniel Rueckert,et al.  Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data , 2006, NeuroImage.

[32]  Nick C Fox,et al.  Regional brain volumes distinguish PSP, MSA‐P, and PD: MRI‐based clinico‐radiological correlations , 2006, Movement disorders : official journal of the Movement Disorder Society.

[33]  Nick C Fox,et al.  Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy. , 2006, Brain : a journal of neurology.

[34]  Z. Wszolek,et al.  New and reliable MRI diagnosis for progressive supranuclear palsy , 2006, Neurology.

[35]  N. Bresolin,et al.  Parkinson's Disease and Brain Mitochondrial Dysfunction: A Functional Phosphorus Magnetic Resonance Spectroscopy Study , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  Joseph James Duffy,et al.  Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP , 2006, Neurology.

[37]  Maria Luisa Gorno-Tempini,et al.  Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. , 2006, Archives of neurology.

[38]  D Perani,et al.  Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[39]  B. Boeve,et al.  Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome , 2005, Movement disorders : official journal of the Movement Disorder Society.

[40]  Joseph James Duffy,et al.  Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia , 2005, Neurocase.

[41]  A. Lees,et al.  Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. , 2005, Brain : a journal of neurology.

[42]  Nick C Fox,et al.  Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy , 2005, Neurology.

[43]  M. Oda,et al.  Progressive supranuclear palsy: MRI and pathological findings , 1996, Neuroradiology.

[44]  Y. Sugai,et al.  Morning glory sign: a particular MR finding in progressive supranuclear palsy. , 2004, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[45]  Nick C. Fox,et al.  Voxel-based morphometry detects patterns of atrophy that help differentiate progressive supranuclear palsy and Parkinson's disease , 2004, NeuroImage.

[46]  A. Righini,et al.  MR imaging of the superior profile of the midbrain: differential diagnosis between progressive supranuclear palsy and Parkinson disease. , 2004, AJNR. American journal of neuroradiology.

[47]  Niall Quinn,et al.  Accuracy of clinical diagnosis of progressive supranuclear palsy , 2004, Movement disorders : official journal of the Movement Disorder Society.

[48]  Johannes Dichgans,et al.  Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration , 2004, NeuroImage.

[49]  Mircea Ariel Schoenfeld,et al.  Differentiation of idiopathic Parkinson's disease, multiple system atrophy, progressive supranuclear palsy, and healthy controls using magnetization transfer imaging , 2004, NeuroImage.

[50]  G K Wenning,et al.  Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[51]  S. Aoki,et al.  Morning glory sign is not prevalent in progressive supranuclear palsy. , 2004, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

[52]  Roland G Henry,et al.  DTI‐based three‐dimensional tractography detects differences in the pyramidal tracts of infants and children with congenital hemiparesis , 2003, Journal of magnetic resonance imaging : JMRI.

[53]  Shu-Wei Sun,et al.  Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia , 2003, NeuroImage.

[54]  Irene Litvan,et al.  Update on epidemiological aspects of progressive supranuclear palsy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[55]  K. Arai,et al.  Study of the rostral midbrain atrophy in progressive supranuclear palsy , 2003, Journal of the Neurological Sciences.

[56]  D W Dickson,et al.  Atrophy of superior cerebellar peduncle in progressive supranuclear palsy , 2003, Neurology.

[57]  Denis Le Bihan,et al.  Looking into the functional architecture of the brain with diffusion MRI , 2003, Nature Reviews Neuroscience.

[58]  R. Kreis,et al.  Cerebral Energy Metabolism in Phenylketonuria: Findings by Quantitative In Vivo 31P MR Spectroscopy , 2003, Pediatric Research.

[59]  C Kremser,et al.  Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy , 2003, Neurology.

[60]  F. Tison,et al.  Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD , 2003, Journal of Neural Transmission.

[61]  John Russell,et al.  Dysmyelination Revealed through MRI as Increased Radial (but Unchanged Axial) Diffusion of Water , 2002, NeuroImage.

[62]  D. Burn,et al.  Progressive supranuclear palsy: where are we now? , 2002, The Lancet Neurology.

[63]  J. Currie,et al.  Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy. , 2002, Brain : a journal of neurology.

[64]  H. Hanyu,et al.  Magnetisation transfer measurements of the subcortical grey and white matter in Parkinson's disease with and without dementia and in progressive supranuclear palsy , 2001, Neuroradiology.

[65]  L Solymosi,et al.  Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy. , 2001, Archives of neurology.

[66]  P Sachdev,et al.  Magnetic resonance spectroscopy in AD , 2001, Neurology.

[67]  F. Tison,et al.  Oral zolmitriptan is effective in the acute treatment of cluster headache , 2000, Neurology.

[68]  K. Abe,et al.  Proton magnetic resonance spectroscopy of patients with parkinsonism , 2000, Brain Research Bulletin.

[69]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[70]  N. Hashimoto,et al.  Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy , 2000, Journal of Neural Transmission.

[71]  F. Barkhof,et al.  Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability , 1999, Annals of neurology.

[72]  D. Radice,et al.  Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy , 1999, Neurology.

[73]  P. Lamberti,et al.  Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes , 1999, The Italian Journal of Neurological Sciences.

[74]  K O Lim,et al.  In vivo spectroscopic quantification of the N‐acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: Effects of normal aging , 1999, Magnetic resonance in medicine.

[75]  C Trenkwalder,et al.  The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? , 1999, Archives of neurology.

[76]  M. Skalej,et al.  Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.

[77]  Florence Pasquier,et al.  Early diagnosis of dementia: neuropsychology , 1999, Journal of Neurology.

[78]  M. Hallett,et al.  Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. , 1997, Brain : a journal of neurology.

[79]  F Federico,et al.  Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[80]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.

[81]  D J Jenden,et al.  In vivo 1H MRS choline: correlation with in vitro chemistry/histology. , 1996, Life sciences.

[82]  C. Beaulieu,et al.  Determinants of anisotropic water diffusion in nerves , 1994, Magnetic resonance in medicine.

[83]  E. Ciceri,et al.  Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders. , 1994, Journal of neural transmission. Supplementum.

[84]  F. Grandas,et al.  Progressive supranuclear palsy and corticobasal ganglionic degeneration: differentiation by clinical features and neuroimaging techniques. , 1994, Journal of neural transmission. Supplementum.

[85]  D. Gadian,et al.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[86]  P Soliveri,et al.  MR Imaging in Progressive Supranuclear Palsy and Shy‐Drager Syndrome , 1989, Journal of computer assisted tomography.

[87]  R. Balaban,et al.  Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo , 1989, Magnetic resonance in medicine.